← Back to headlines
Maxim Upgrades Gilead Sciences (GILD) to ‘Buy’
Maxim has upgraded Gilead Sciences (GILD) to a ‘Buy’ rating. This reflects a positive outlook on the pharmaceutical company's stock.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Nigeria Reports 4.43 Percent Economic Growth in Second Quarter
27m ago
Prediction Platform Kalshi Permanently Bans George Santos Over Insider Trading
30m ago
Trump Administration Announces Major Oil Deal with Venezuela and Drug Pricing Pacts
57m ago
Aon Agrees to Acquire USI Insurance Services in $17 Billion Deal
58m ago